Incidence of Malignant Melanoma in Auckland, New Zealand: Highest Rates in the World

@article{Jones1999IncidenceOM,
  title={Incidence of Malignant Melanoma in Auckland, New Zealand: Highest Rates in the World},
  author={W O Jones and C. Richard Harman and Alexander K. Ng and James H. F. Shaw},
  journal={World Journal of Surgery},
  year={1999},
  volume={23},
  pages={732-735}
}
Abstract. The calculation of incidence rates of melanoma in New Zealand has been hampered in the past by incomplete registration of cases. The aim of this study was to document the incidence of melanoma in the Auckland Caucasian population and to define the pathologic characteristics of these lesions. Data were collected for the Auckland region from the New Zealand Cancer Registry and the Auckland Melanoma Unit database for 1995 and combined with census statistics to give the crude and age… 

The incidence of melanoma is increasing in the susceptible young Australian population.

There was a significant increase in the number of young Australians at low risk for melanoma in 1982, and the rate increased from 5.9 per 100,000 in 1982 to 6.3 in 2009.

Extremely high levels of melanoma in Tauranga, New Zealand: Possible causes and comparisons with Australia and the northern hemisphere

The Tauranga region of New Zealand has an exceptionally high incidence of invasive and in situ melanomas, likely related to environmental, geographical and societal factors, including relatively high levels of UV exacerbated in recent times by ozone depletion, relatively cool summer temperatures which encourage outdoor exposure, and relatively fair skin colouring.

Epidemiology of melanoma in situ in New Zealand: 2008-2012.

New information is provided about the epidemiology of MIS in New Zealand and its relevance to clinical practice and public education strategies may be beginning to show effect with the goal of increasing prevention and earlier detection and treatment to enable decrease in melanoma mortality.

Management of Head and Neck Melanoma

A database of 3,500 patients with either head and neck primary melanoma or regional melanoma involving cervical regional nodes or parotid nodes managed in the Auckland area 1984-2005 is reviewed.

Clinical Epidemiology of Invasive Cutaneous Malignant Melanoma in the Austrian Province Styria in the Years 2001–2003 and Its Relationship with Local Geographical, Meteorological and Economic Data

The high incidence of invasive melanoma in Styria is unclear and a causal relationship between higher income and melanoma incidence remains speculative, but further investigations, especially concerning lifestyle and environmental factors, may unravel additional causative factors.

Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.

Worldwide, lentigo maligna melanoma (LMM) comprises 4%-15% of cutaneous melanoma and occurs less commonly than superficial spreading or nodular subtypes. We assessed the incidence of melanoma

Melanoma epidemiology and trends.

Malignant melanoma in South Wales: changing trends in presentation (1986–98)

This study reassessed the incidence of invasive MM in this defined population in South Wales over a similar 3 year period and identified 186 cases of MM, which is the highest published standard incidence to date from the UK and certainly one of the highest in Europe.

Ghosts in the machine: the experiences of Maori in the New Zealand health system.

  • J. Koea
  • Medicine
    The New Zealand medical journal
  • 2008
Strategies to encourage the early detection of melanoma in New Zealand have not yet reduced the incidence of thick melanomas, and there were statistically significant associations for age, gender, ethnic group, and type of melanomas with melanoma thickness.
...

References

SHOWING 1-10 OF 27 REFERENCES

Malignant melanoma in Auckland, New Zealand.

The incidence of malignant melanoma in New Zealand is similar to that in Scandinavia, being higher than in the United Kingdom and lower than that in Queensland, Australia.

Increasing incidence of cutaneous melanoma in Queensland, Australia.

Although increased awareness and earlier diagnosis appear to have accompanied increased incidence, increased exposure to solar UV radiation during the past 50 years appears to be the most likely explanation for the rise in incidence rates.

Problems with registration of cutaneous malignant melanoma in England.

The aim of the study was to assess the completeness and accuracy of cancer registration for cutaneous malignant melanoma in England and Scotland from 1987 to 1989 and found the registries are best at recording thick or late-stage melanomas.

Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

The Scottish Melanoma Group was established in 1979 to assess mortality from and incidence, features, pathological data, and management of cutaneous malignant melanoma in Scotland and data about incidence and mortality over eleven years in relation to anatomical site and pathological types are presented.

Melanoma incidence in Tauranga 1980-9.

Age specific rates showed a double peak in middle aged and elderly age groups due to female rates peaking at 40 to 59 and male rates peering at 65+.

Targeting early detection of malignant melanoma of the skin.

Age standardised incidence rates for malignant melanoma of the skin in the nonMaori population increased over 12 years to 1985-6 and among older age groups melanomas were less likely to be localised at diagnosis.

Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures.

Melanoma epidemiology.

Combined analyses and methodologic studies have refined estimation of the effects of risk factors and studies of the development of nevi show that they are robust risk markers for melanoma and share some epidemiologic features with melanoma.

The melanoma epidemic. Is increased surveillance the solution or the problem?

It is not clear whether the increase in the number of melanoma cases diagnosed reflects an actual increase in real disease, and could this increase be in part a product of aggressive surveillance resulting in the identification of "atypical" pigmented skin tumors of limited or nonexistent potential for malignant behavior.